Episode
Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis
- Podcast
- The IMID Forum
- Published
- May 15, 2026
- Duration seconds
- 1315
- Processing state
not_requested- Canonical source
- https://soundcloud.com/imidforum/discussing-axspa-biologic
Actions
POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces anterior uveitis flares in high-risk axSpA and the effect of secukinumab dose escalation on MRI inflammation and damage in axSpA.